The value of Naproxen has increased in the US import market in the first month of 2026. The price of Naproxen has increased in January which was driven by the upward movement of the prices across the supply chain. The price increase in the US has mirrored the price trend of the Chinese export market. The market has observed a period of procurement urgency, inventory management and disciplined supplier prices. The downstream pharmaceutical manufacturers in the US have entered the new production cycles in January. The buyers have reassessed their stock position and identified the inventory gaps that were created by conservative procurement in the previous cycle. The tight inventory levels have prompted the procurers to secure Naproxen early in the first quarter. The market increase in January was demand led as the buyers have prioritized supply security over price sensitivity. The market insights of ChemAnalyst and their forecast analysis will help the market participants of Naproxen to mitigate volatility and maximize their opportunities when costs soften.
